Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
October 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
K-H Liesenfeld, T Lehr, C Dansirikul, et al.
Circulation
|
January 29, 2003
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial
J P Ottervanger, P Armstrong, E S Barnathan, et al.
Heart (British Cardiac Society)
|
March 19, 2005
Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial
R C Welsh, W Chang, P Goldstein, et al.
Journal of Internal Medicine
|
October 19, 2017
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial
M Proietti, Z Hijazi, U Andersson, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 17, 2015
Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial
B D Westenbrink, M Alings, S J Connolly, et al.
Clinical Cardiology
|
May 22, 1998
Management strategies for a better outcome in unstable coronary artery disease
R W Campbell, L Wallentin, F W Verheugt, et al.
Journal of Internal Medicine
|
May 1, 2020
Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
H Røsjø, Z Hijazi, T Omland, et al.
Circulation
|
July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
L Wallentin, P Goldstein, P W Armstrong, et al.
Clinical Cardiology
|
September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council
F W Verheugt, R C Becker, M E Bertrand, et al.
Journal of Internal Medicine
|
September 30, 2017
Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease
E Hagström, F Norlund, A Stebbins, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Journal of Thrombosis and Haemostasis : JTH
|
October 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
K-H Liesenfeld, T Lehr, C Dansirikul, et al.
Circulation
|
January 29, 2003
Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial
J P Ottervanger, P Armstrong, E S Barnathan, et al.
Heart (British Cardiac Society)
|
March 19, 2005
Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial
R C Welsh, W Chang, P Goldstein, et al.
Journal of Internal Medicine
|
October 19, 2017
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial
M Proietti, Z Hijazi, U Andersson, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 17, 2015
Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial
B D Westenbrink, M Alings, S J Connolly, et al.
Clinical Cardiology
|
May 22, 1998
Management strategies for a better outcome in unstable coronary artery disease
R W Campbell, L Wallentin, F W Verheugt, et al.
Journal of Internal Medicine
|
May 1, 2020
Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
H Røsjø, Z Hijazi, T Omland, et al.
Circulation
|
July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
L Wallentin, P Goldstein, P W Armstrong, et al.
Clinical Cardiology
|
September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council
F W Verheugt, R C Becker, M E Bertrand, et al.
Journal of Internal Medicine
|
September 30, 2017
Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease
E Hagström, F Norlund, A Stebbins, et al.
Page
of 19